Showing results (1-10 of 678) with videos related to
Sort By:
Pageof 68
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|June 5, 2009
Using patent data to assess the value of pharmaceutical innovationAaron S Kesselheim, Jerry AvornNature Reviews. Drug Discovery|May 18, 2013
The most transformative drugs of the past 25 years: a survey of physiciansAaron S Kesselheim, Jerry AvornJAMA|February 17, 2005
University-based science and biotechnology products: defining the boundaries of intellectual propertyAaron S Kesselheim, Jerry AvornHealth Affairs (Project Hope)|October 11, 2012
The Food and Drug Administration has the legal basis to restrict promotion of flawed comparative effectiveness researchAaron S Kesselheim, Jerry AvornJAMA Network Open|April 19, 2022
Use of Extrapolation in New Drug Approvals by the US Food and Drug AdministrationDaniel Feldman, Jerry Avorn, Aaron S KesselheimCirculation. Cardiovascular Quality and Outcomes|October 25, 2012
Origins of medical innovation: the case of coronary artery stentsShuai Xu, Jerry Avorn, Aaron S KesselheimJAMA Internal Medicine|August 25, 2015
Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014Jing Luo, Jerry Avorn, Aaron S KesselheimPlos One|February 18, 2014
Clinicians' contributions to the development of coronary artery stents: a qualitative study of transformative device innovationAaron S Kesselheim, Shuai Xu, Jerry AvornJAMA|August 24, 2016
The High Cost of Prescription Drugs in the United States: Origins and Prospects for ReformAaron S Kesselheim, Jerry Avorn, Ameet SarpatwariHealth Affairs (Project Hope)|July 13, 2006
The rise and fall of Natrecor for congestive heart failure: implications for drug policyAaron S Kesselheim, Michael A Fischer, Jerry AvornPageof 68